WINT
Windtree Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+0.00%Margins
Gross margin
-387.8%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
344.6%
Return on equity
-250.3%
Return on assets
-2541.5%
Return on invested capital
0.00x
Asset turnover
-$15.1M
Cash from operations
$7.65
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2025